Mirum Pharmaceuticals (MIRM) Revenue (2021 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Revenue of $159.9 million for Q1 2026, up 43.28% year-over-year from $111.6 million in Q1 2025, and up 7.35% quarter-over-quarter from $148.9 million in Q4 2025.
Mirum Pharmaceuticals (MIRM) Revenue (2021 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Revenue history runs 6 years deep, the most recent figure standing at $159.9 million for Q1 2026.
- In Q1 2026, Revenue rose 43.28% year-over-year to $159.9 million; the TTM figure through Mar 2026 stood at $569.6 million (up 50.19% YoY), while the FY2025 annual figure was $521.3 million, up 54.74% from the prior year.
- Revenue for Q1 2026 stood at $159.9 million, up from $148.9 million in the prior quarter.
- The five-year high for Revenue was $159.9 million in Q1 2026, with the low at $12.9 million in Q1 2022.
- The 5-year median for Revenue is $69.6 million (2023), against an average of $75.4 million.
- The sharpest annual moves came in 2022 and 2024: Revenue soared 789.29% in 2022, then jumped 42.93% in 2024.
- Mirum Pharmaceuticals' Revenue stood at $27.9 million in 2022, then surged by 149.24% to $69.6 million in 2023, then surged by 42.93% to $99.4 million in 2024, then jumped by 49.81% to $148.9 million in 2025, then advanced by 7.35% to $159.9 million in 2026.
- Business Quant data shows MIRM's Revenue at $159.9 million in Q1 2026, $148.9 million in Q4 2025, and $133.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | 176.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 176.24 Mn |
| Mar 31, 2026 | 159.88 Mn |
| Dec 31, 2025 | 148.93 Mn |
| Sep 30, 2025 | 133.01 Mn |
| Jun 30, 2025 | 127.79 Mn |
| Mar 31, 2025 | 111.59 Mn |
| Dec 31, 2024 | 99.41 Mn |
| Sep 30, 2024 | 90.38 Mn |
| Jun 30, 2024 | 77.88 Mn |
| Mar 31, 2024 | 69.22 Mn |
| Dec 31, 2023 | 69.55 Mn |
| Sep 30, 2023 | 47.73 Mn |
| Jun 30, 2023 | 37.50 Mn |
| Mar 31, 2023 | 31.60 Mn |
| Dec 31, 2022 | 27.91 Mn |
| Sep 30, 2022 | 18.78 Mn |
| Jun 30, 2022 | 17.48 Mn |
| Mar 31, 2022 | 12.89 Mn |
| Dec 31, 2021 | 3.14 Mn |
| Sep 30, 2021 | 5.00 Mn |